OUROFINO S/A (OFSA3) Main Indicators
Basic Data - OFSA3
Company | OUROFINO S/A |
Corporate Name | OURO FINO SAUDE ANIMAL PARTICIPACOES S.A. |
Registration Status | ATIVO |
Issuer Status | FASE OPERACIONAL |
Listing Segment | Novo Mercado |
Activity | Atividade de comercialização de produtos destinados ao setor de saúde animal. |
Share | OFSA3 |
Quote Date | 11/19/2024 |
Share Type | ON |
Last Closing | R$ 22.65 |
Quotation Factor | 1 Share |
Financial Volume | R$ 37.84 thousand |
Last Statement | ITR - 09/30/2024 |
Sector | Saúde |
Subsector | Medicamentos e Outros Produtos |
Segment | Medicamentos e Outros Produtos |
Participation Indexes | IGC, IGNM, ITAG |
Updated 11/21/2024 |
Relative Prices - OFSA3
Price/Earnings | 13.42 |
Price/SBV | 1.68 |
Price/Net Sales | 1.27 |
Price/CFO | 18.72 |
Price/FCF | 21.10 |
Price/Total Assets | 0.93 |
Price/EBIT | 8.56 |
Price/Working Capital | 2.04 |
Price/NCAV | 60.64 |
EV/EBIT | 9.26 |
EV/EBITDA | 7.35 |
EV/Net Sales | 1.38 |
EV/CFO | 20.24 |
EV/FCF | 22.82 |
EV/Total Assets | 1.01 |
Company Market Cap | R$ 1.22 B |
Enterprise Value | R$ 1.32 B |
Current Financial Statement Date | 09/30/2024 |
Current Share Price | R$ 22.65 |
Share Price Date | 11/19/2024 |
Dividend Yield | 2.71% |
Updated 11/21/2024 |
Income Statement - OFSA3
Net Revenue | R$ 958.76 M |
Gross Result | R$ 465.02 M |
EBIT | R$ 142.69 M |
Depreciation and Amortization | - R$ 37.21 M |
EBITDA | R$ 179.90 M |
Net Profit | R$ 91.06 M |
Net Profit/Share | R$ 1.69 |
Updated 11/07/2024 |
Net Revenue | R$ 282.56 M |
Gross Result | R$ 154.31 M |
EBIT | R$ 62.49 M |
Depreciation and Amortization | - R$ 9.34 M |
EBITDA | R$ 71.83 M |
Net Profit | R$ 41.61 M |
Profit/Share | R$ 0.77 |
Updated 11/07/2024 |
Price and Volume Behavior - OFSA3
Lowest Price 52 weeks | R$ 18.50 |
Highest Price 52 weeks | R$ 25.60 |
Variation 2024 | -7.74% |
Variation 1 year | 8.99% |
Variation 2 years(total) | -0.32% |
Variation 2 years(yearly) | -0.16% |
Variation 3 years(total) | -7.32% |
Variation 3 years(yearly) | -2.50% |
Variation 4 years(total) | -22.03% |
Variation 4 years(yearly) | -6.03% |
Variation 5 years(total) | -33.65% |
Variation 5 years(yearly) | -7.87% |
Average Daily Volume (3 months) | R$ 96.21 thousand |
Updated 11/21/2024 |
Returns and Margins - OFSA3
Return on Initial Tangible Capital | 13.53% |
Return on Initial Invested Capital | 12.47% |
Pre-Tax Return on Initial Tangible Capital | 20.50% |
Pre-Tax Return on Initial Invested Capital | 18.90% |
Return on Initial Shareholder´s Equity | 13.60% |
Return on Initial Asset | 7.17% |
Gross Margin | 48.50% |
Net Margin | 9.50% |
EBIT Margin | 14.88% |
EBITDA Margin | 18.76% |
Initial Asset Turnover | 0.76 |
Financial Leverage | 1.80 |
Liabilities/Net Worth | 0.80 |
Net Debt/EBITDA | 0.55 |
Updated 11/07/2024 |
Balance Sheet - OFSA3
Cash and Cash Equivalents | R$ 259.28 M |
Total Assets | R$ 1.31 B |
Short-Term Debt | R$ 54.33 M |
Long-Term Debt | R$ 304.48 M |
Gross Debt | R$ 358.81 M |
Net Debt | R$ 99.53 M |
Shareholder´s Equity | R$ 728.98 M |
Share Book Value | R$ 13.51 |
Common Shares | 53,949,006 |
Preferred Shares | 0 |
Total | 53,949,006 |
Common Shares in Treasury | 181,400 |
Preferred Shares in Treasury | 0 |
Total in Treasury | 181,400 |
Common Shares (Except Treasury) | 53,767,606 |
Preferred Shares (Except Treasury) | 0 |
Total (Except Treasury) | 53,767,606 |
Updated 11/07/2024 |
Cash Flow - OFSA3
Operating Cash Flow | R$ 65.28 M |
Cash Flow from Investments | - R$ 37.15 M |
Financing Cash Flow | - R$ 38.12 M |
Increase (Reduction) in Cash and Equivalents | - R$ 9.34 M |
Updated 11/07/2024 |
Operating Cash Flow | - R$ 22.68 M |
Cash Flow from Investments | - R$ 8.57 M |
Financing Cash Flow | - R$ 52.72 M |
Increase (Reduction) in Cash and Equivalents | - R$ 83.97 M |
Updated 11/07/2024 |
Experimental - OFSA3
CAPEX 3 months | - R$ 2.99 M |
Free Cash Flow 3 months | - R$ 25.67 M |
CAPEX 12 months | - R$ 7.37 M |
Free Cash Flow 12 months | R$ 57.91 M |
Updated 11/07/2024 |